RAFFA WEALTH MANAGEMENT, LLC’s Amicus Therapeutics FOLD Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-96	Closed	-$1.11K	–	1143
2021 Q4	$1.11K	Hold	96	–	–	﹤0.01%	831
2021 Q3	$917	Hold	96	–	–	﹤0.01%	851
2021 Q2	$925	Sell	96 -1	-1%	-$10	﹤0.01%	862
2021 Q1	$958	Sell	97 -20	-17%	-$310	﹤0.01%	840
2020 Q4	$2.7K	Buy	117 +20	+21%	+$409	﹤0.01%	481
2020 Q3	$1.37K	Sell	97 -13	-12%	-$189	﹤0.01%	581
2020 Q2	$1.66K	Hold	110	–	–	﹤0.01%	519
2020 Q1	$1.02K	Hold	110	–	–	﹤0.01%	588
2019 Q4	$1.07K	Hold	110	–	–	﹤0.01%	606
2019 Q3	$882	Buy	+110	New	+$1.19K	﹤0.01%	641

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's FOLD Position: Q1 2022 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of Amicus Therapeutics (FOLD) in Q1 2022, closing a stake of 96 shares — an estimated $1.11K sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in FOLD in Q3 2019 and held it in 10 quarters. The position peaked at $2.7K in Q4 2020. 217 funds tracked by Wall St. Rank hold FOLD as of Q1 2022.

RAFFA WEALTH MANAGEMENT, LLC reported no remaining Amicus Therapeutics position as of Q1 2022 after selling out during the quarter.
RAFFA WEALTH MANAGEMENT, LLC sold 96 Amicus Therapeutics shares in Q1 2022, an estimated $1.11K.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Amicus Therapeutics in Q3 2019 and held it in 10 quarters.
RAFFA WEALTH MANAGEMENT, LLC's Amicus Therapeutics position peaked at $2.7K in Q4 2020.
217 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2022.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q1 2022, filed 27 Jul 2026.